Barclays
PASG icon

Barclays’s Passage Bio PASG Stock Holding History

Barclays’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66K Hold
212
– – ﹤0.01% 4868
2025
Q4 		$2.5K Hold
212
– – ﹤0.01% 5032
2025
Q3 		$1.7K Buy
212
+1
+0.5% +$7 ﹤0.01% 5155
2025
Q2 		$1.69K Hold
211
– – ﹤0.01% 5046
2025
Q1 		$1.49K Sell
211
-447
-68% -$4.83K ﹤0.01% 5018
2024
Q4 		$7.46K Hold
658
– – ﹤0.01% 5023
2024
Q3 		$9.21K Hold
658
– – ﹤0.01% 4982
2024
Q2 		$10.4K Hold
658
– – ﹤0.01% 4514
2024
Q1 		$17.8K Hold
658
– – ﹤0.01% 4766
2023
Q4 		$13.3K Hold
658
– – ﹤0.01% 4949
2023
Q3 		$8.65K Hold
658
– – ﹤0.01% 4324
2023
Q2 		$12.4K Hold
658
– – ﹤0.01% 4204
2023
Q1 		$12.6K Hold
658
– – ﹤0.01% 4718
2022
Q4 		$18.2K Hold
658
– – ﹤0.01% 4825
2022
Q3 		$16K Sell
658
-20
-3% -$788 ﹤0.01% 4142
2022
Q2 		$32K Sell
678
-319
-32% -$14.9K ﹤0.01% 4220
2022
Q1 		$62K Buy
+997
New +$82.2K ﹤0.01% 4022

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays's PASG Position: Q1 2026 in Review

Barclays held its Passage Bio (PASG) position steady in Q1 2026 at 212 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #4868.

Barclays first reported a position in PASG in Q1 2022 and has held it in 17 quarters since. The position peaked at $62K in Q1 2022. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Barclays held 212 shares of Passage Bio worth $1.66K as of Q1 2026.
  • Barclays left its Passage Bio share count unchanged in Q1 2026.
  • Passage Bio made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4868 holding.
  • Barclays first reported a position in Passage Bio in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Passage Bio position peaked at $62K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.